In This Guide
- DC 5025 Rating Criteria: 10%, 20%, and 40%
- Gulf War Presumptive Service Connection
- January 2026 Geographic Expansion
- The Diagnostic Criteria Trap
- Secondary Conditions That Multiply Your Rating
- The TDIU Bridge Strategy
- Key Case Law: Stewart and Bufkin
- Why 80%+ of Gulf War Claims Get Denied
- Your Action Steps
DC 5025 Rating Criteria: 10%, 20%, and 40%
The VA rates fibromyalgia under Diagnostic Code 5025 (38 CFR § 4.71a). Unlike most musculoskeletal conditions, there are only three possible ratings — and no path to 100% schedular through fibromyalgia alone.
| Rating | Criteria | Key Qualifier |
|---|---|---|
| 10% | Widespread musculoskeletal pain and tender points | Requires continuous medication for control |
| 20% | Same symptoms as 10% | Episodic, present more than 1/3 of the time, triggered by environmental or emotional stress |
| 40% | Same symptoms as 10% | Constant or nearly constant AND refractory to therapy |
Notice the jump from 20% to 40% — there is no 30% rating for fibromyalgia. The word "refractory" is what separates 20% from 40%. It means you've tried treatments and they haven't controlled your symptoms. If your medical records show you've been through multiple medications, physical therapy, and lifestyle modifications without adequate relief, you meet the 40% standard.
Gulf War Presumptive Service Connection
This is where fibromyalgia claims differ from nearly every other VA condition. If you served in the Southwest Asia theater of operations on or after August 2, 1990, fibromyalgia is a presumptive condition under 38 CFR § 3.317.
What "presumptive" means in practice:
- No nexus letter required. You don't need a doctor to connect your fibromyalgia to service.
- No specific in-service event required. You don't need to point to a particular exposure or injury.
- Only three things to prove: (1) You served in a qualifying location, (2) you have a fibromyalgia diagnosis, and (3) your symptoms manifested by December 31, 2026.
Fibromyalgia qualifies because the VA classifies it as a Medically Unexplained Chronic Multisymptom Illness (MUCMI) — a condition whose cause and underlying mechanism remain medically inconclusive. This classification is the legal foundation for presumptive status.
January 2026 Geographic Expansion
On January 22, 2026, the VA finalized a rule (91 FR 2713) that expanded who qualifies as a "Persian Gulf veteran" for presumptive purposes. If you were previously denied because of where you served, check this list:
Gulf War Veterans (Service on or after August 2, 1990)
- Iraq, Kuwait, Saudi Arabia, Bahrain, Qatar, UAE, Oman (original locations)
- Somalia — NEW (added January 2026)
Post-9/11 Veterans (Service on or after September 19, 2001)
- Afghanistan, Israel, Egypt, Turkey, Syria, Jordan (confirmed under § 3.317)
- Djibouti, Lebanon, Yemen, Uzbekistan (covered under § 3.320 framework)
The Diagnostic Criteria Trap
Here's a problem most veterans don't know about until it costs them a rating: the VA's fibromyalgia exam form is 35 years out of date.
What the VA Uses (1990 ACR Criteria)
- Physical tender point exam at 18 anatomical sites
- Must have at least 11 of 18 positive
- Widespread pain for 3+ months
- Must rule out other diagnoses
What Medicine Uses Now (2010/2016 ACR)
- Widespread Pain Index (WPI) score
- Symptom Severity (SS) score
- No tender point exam required
- Valid "irrespective of other diagnoses"
The 1990 tender point exam has a documented gender bias — it measures pressure sensitivity, which is physiologically different between men and women. Research shows approximately 12% of people with legitimate fibromyalgia will fail the 1990 tender point test. Male Gulf War veterans are disproportionately affected.
This means your private rheumatologist can diagnose you with fibromyalgia using current medical standards, and then the VA's C&P examiner can say you don't meet criteria — because they're using a different test.
The Workaround
Ask your treating physician to document both sets of criteria in a single report:
- 2010/2016 scores: Widespread Pain Index (WPI) and Symptom Severity (SS) scores — the current clinical standard
- 1990 tender point findings: Document all 18 anatomical sites for VA DBQ compatibility
If your tender points come up short, use the Stewart v. Wilkie argument (see case law section below): even without sufficient tender points, fibromyalgia's pathophysiology remains medically inconclusive, which preserves MUCMI status under 38 CFR § 3.317.
Secondary Conditions That Multiply Your Rating
The 40% cap on fibromyalgia is not the end of the road. It's the starting point. The real strategy is claiming secondary conditions that are rated under their own diagnostic codes. These stack on top of your fibromyalgia rating through VA combined rating math.
| Secondary Condition | Diagnostic Code | Rating Range | Connection to Fibromyalgia |
|---|---|---|---|
| IBS | DC 7319 | 0–30% | Shared gut-brain axis dysregulation; up to 70% co-occurrence |
| Sleep Apnea | DC 6847 | 0–100% | Fibromyalgia affects airway muscles and nerves |
| Migraines | DC 8100 | 0–50% | Central nervous system sensitization triggers migraine cascades |
| Depression | Mental Health formula | 0–100% | Fibromyalgia patients are 3x more likely to develop major depression (CDC data) |
| Anxiety | Mental Health formula | 0–100% | Chronic pain leads to social isolation and anxiety |
| GERD | DC 7206 | 0–80% | Acid reflux heavily associated with fibromyalgia |
| Chronic Fatigue Syndrome | DC 6354 | 10–100% | Both MUCMI; ratable separately if independently documented |
| TMJ | DC 9905 | 10–50% | Muscle tension and nervous system hypersensitivity |
The TDIU Bridge Strategy
Here's why the 40% fibromyalgia rating is more valuable than it looks: it serves as the anchor for Total Disability Individual Unemployability (TDIU).
TDIU requirements:
- Combined rating of at least 70%
- At least one condition rated at 40% or higher
- Unable to secure or maintain substantially gainful employment due to service-connected disabilities
Fibromyalgia at 40% checks the single-condition box. Add secondary conditions — depression at 50%, IBS at 30%, migraines at 30% — and you're well past the 70% combined threshold. TDIU pays at the 100% rate (currently $3,737.85/month for a single veteran in 2026).
Key Case Law: Stewart and Bufkin
Stewart v. Wilkie (2018) — Your Best Weapon
Stewart v. Wilkie, 30 Vet.App. 383 (2018), is the most important case for fibromyalgia claims. The Court of Appeals for Veterans Claims held that MUCMI status is established if either the etiology (cause) or pathophysiology (mechanism) is inconclusive. Not both — either one.
Fibromyalgia's pathophysiology (central sensitization) remains medically inconclusive. This means even if a VA examiner tries to argue the cause is "known," the mechanism is still inconclusive, and MUCMI status holds.
This case was confirmed actively applied at the BVA level in a 2025 decision (case A25020570), where the Board cited Stewart verbatim to grant Gulf War presumptive service connection. The VA attempted to appeal Stewart to the Federal Circuit but voluntarily dismissed — the decision is binding.
Bufkin v. Collins (2025) — An Adverse Development
Bufkin v. Collins, 604 U.S. 369 (March 5, 2025), is a Supreme Court decision that went against veterans. The Court held 7-2 that the VA's determination of whether evidence is in "approximate balance" under the benefit-of-the-doubt rule is a factual question — meaning the CAVC can only review it for "clear error," not independently.
Why this matters for fibromyalgia: your condition has no definitive lab markers. Evidence is often in genuine "approximate balance" — your doctor says one thing, the C&P examiner says another. Before Bufkin, you could argue at the CAVC that the BVA got the balance wrong. Now the CAVC will defer to the BVA's call unless it was clearly erroneous.
What To Do About Bufkin
- Build the strongest possible record before the BVA. Don't save your best evidence for appeal — the BVA's factual finding now gets deference.
- Explicitly invoke benefit-of-the-doubt at every stage — initial claim, Higher-Level Review, and BVA hearing. Cite 38 CFR § 3.102 and 38 U.S.C. § 5107(b) by name.
- Focus CAVC appeals on Stewart legal errors. If the BVA relied on a C&P opinion that failed to address both etiology and pathophysiology under Stewart, that's a legal error — still reviewed de novo at the CAVC even after Bufkin.
Why 80%+ of Gulf War Claims Get Denied
Despite the presumptive framework, Gulf War illness claims have a documented denial rate exceeding 80%. This is not speculation — it's from the VA's own data presented to Congress and independently confirmed by the GAO.
- GAO 2017: 80%+ denial rate for Gulf War illness claims
- Congressional hearing (VA data): 16% approval, 84% denial
- Vietnam Veterans of America: 90% denial for undiagnosed disability claims
The documented causes of wrongful denials include:
- C&P examiners not trained on MUCMI standards or Stewart v. Wilkie
- Applying direct service connection standards instead of presumptive standards
- Requiring nexus letters when presumptive status eliminates that requirement
- Using the outdated 1990 diagnostic criteria to reject modern diagnoses
- Failing to apply benefit-of-the-doubt in close cases
- Misapplying pyramiding rules to deny valid secondary conditions
The appeal success rate tells the real story: roughly 40% of BVA appeals result in favorable outcomes. That means nearly half of initial denials were wrong. If you're denied, appeal.
Your Action Steps
If You're a Gulf War Veteran
- File an Intent to File today at va.gov to lock in your effective date
- Get a fibromyalgia diagnosis with documentation using BOTH 1990 and 2010/2016 ACR criteria
- Claim secondary conditions simultaneously — don't wait for the fibromyalgia decision
- Cite Stewart v. Wilkie in your claim submission and any appeal
- Check the January 2026 geographic expansion if you served in Somalia or Post-9/11 locations
- Do not wait until late 2026 — the December 31, 2026 deadline is real and confirmed
If You're Not a Gulf War Veteran
- Get a nexus letter connecting fibromyalgia to service (required without presumptive status)
- Document the dual criteria — the diagnostic mismatch affects all veterans, not just Gulf War
- Secondary service connection is an alternative path — if fibromyalgia developed because of a service-connected condition (like PTSD), file it as secondary under 38 CFR § 3.310
If You Were Already Denied
- Check your denial letter — does it cite § 1117 and apply presumptive standards? If not, that's an error.
- Higher-Level Review if the evidence was strong but misapplied (~50% success rate)
- Supplemental Claim with new evidence if the initial evidence was insufficient
- BVA hearing for the strongest cases — you get a Veterans Law Judge and can submit new evidence
Don't Navigate This Alone
Fibromyalgia claims are among the most frequently denied — and most frequently overturned on appeal. Our AI-powered analysis can identify the strongest arguments for your specific situation.
Analyze Your Claim FreeLegal References
- 38 CFR § 4.71a, Diagnostic Code 5025 — Fibromyalgia rating criteria
- 38 CFR § 3.317 — Gulf War presumptive service connection
- 38 CFR § 3.310 — Secondary service connection
- 38 CFR § 4.14 — Pyramiding prohibition
- 38 CFR § 3.102 / 38 U.S.C. § 5107(b) — Benefit of the doubt
- 91 FR 2713 (January 22, 2026) — Geographic eligibility expansion
- Stewart v. Wilkie, 30 Vet.App. 383 (2018) — MUCMI etiology/pathophysiology standard
- Bufkin v. Collins, 604 U.S. 369 (2025) — Benefit-of-the-doubt clear error standard
- Goodman v. Shulkin, 870 F.3d 1383 (Fed. Cir. 2017) — Lay evidence in MUCMI determinations